COMPOSITION FOR IN-VIVO DELIVERING mRNA CONTAINING MODIFIED NUCLEOTIDE
Disclosed is a composition for delivering mRNA containing a modified nucleotide including liposomes based on a cationic lipid. The composition for delivering mRNA containing a modified nucleotide has superior storage stability and high expression efficiency in vivo, thus increasing the stability and...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
21.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed is a composition for delivering mRNA containing a modified nucleotide including liposomes based on a cationic lipid. The composition for delivering mRNA containing a modified nucleotide has superior storage stability and high expression efficiency in vivo, thus increasing the stability and efficiency of mRNA vaccines for cancer treatment or mRNA vaccines for preventing viral infections and other mRNA vaccines or therapeutics. |
---|---|
Bibliography: | Application Number: AU20230274159 |